大生農業金融(01103.HK)收到聯交所額外復牌指引
格隆匯4月3日丨大生農業金融(01103.HK)公吿,公司於2023年3月29日收到聯交所信函,其中載列有關恢復H股買賣的額外復牌指引。連同聯交所先前發佈的復牌指引,復牌指引的詳情如下:(i)根據第13.50A條的規定解決導致對2021年年度業績不發表意見的問題,保證毋須再就有關問題發出不發表意見,並披露足夠資料使投資者能夠對公司財務狀況作出知情評估;(ii)證明公司遵守上市規則第13.24條規定;(iii)公佈所有重要資訊以供公司股東及投資者評估公司狀況。若公司的情況有變,聯交所或會修訂或補充復牌指引;及(iv)撤回或駁回針對公司的破產重整申請(或完成破產重整),並解除管理人的任命。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.